Risk of target lesion revascularization after coronary stenting in patients with and without chronic kidney disease

Nephrology Dialysis Transplantation

Volumn 22, Issue 9, 2007, Pages 2578-2585

  Charytan, David ^a   Forman, John P ^a   Cutlip, Donald E ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Angioplasty; Chronic kidney disease; Coronary artery disease; Percutaneous coronary intervention; Restensosis; Revascularization

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORONARY STENT; DISEASE CLASSIFICATION; ELECTIVE SURGERY; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; REGRESSION ANALYSIS; RESTENOSIS; RISK ASSESSMENT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

CORONARY RESTENOSIS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; MYOCARDIUM; RISK FACTORS; STENTS; TIME FACTORS;

EID: 34548393746     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm241     Document Type: Article

References (35)

1. Parfrey PS, Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 1999; 10: 1606-1615
2. NIH. USRDS 2003 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, 2003
3. Gruberg L, Dangas G, Mehran R et al. Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure. Catheter Cardiovasc Interv 2002; 55: 66-72
4. Gruberg L, Weissman NJ, Waksman R et al. Comparison of outcomes after percutaneous coronary revascularization with stents in patients with and without mild chronic renal insufficiency. Am J Cardiol 2002; 89: 54-57
5. Marso SP, Gimple LW, Philbrick JT, DiMarco JP. Effectiveness of percutaneous coronary interventions to prevent recurrent coronary events in patients on chronic hemodialysis. Am J Cardiol 1998; 82: 378-380
6. Ahmed WH, Shubrooks SJ, Gibson CM, Baim DS, Bittl JA. Complications and long-term outcome after percutaneous coronary angioplasty in chronic hemodialysis patients. Am Heart J 1994; 128: 252-255
7. Kahn JK, Rutherford BD, McConahay DR, Johnson WL, Giorgi LV, Hartzler GO. Short- and long-term outcome of percutaneous transluminal coronary angioplasty in chronic dialysis patients. Am Heart J 1990; 119 (3 Pt 1):484-489
8. Fischman DL, Leon MB, Baim DS et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994; 331: 496-501
9. Azar RR, Prpic R, Ho KK et al. Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting. Am J Cardiol 2000; 86: 485-489
10. Sadeghi HM, Stone GW, Grines CL et al. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation 2003; 108: 2769-2775
11. Best PJ, Berger PB, Davis BR et al. Impact of mild or moderate chronic kidney disease on the frequency of restenosis: Results from the PRESTO trial. J Am Coll Cardiol 2004; 44: 1786-1791
12. Best PJ, Lennon R, Ting HH et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 2002; 39: 1113-1119
13. Gruberg L, Waksman R, Ajani AE et al. The effect of intracoronary radiation for the treatment of recurrent in-stent restenosis in patients with chronic renal failure. J Am Coll Cardiol 2001; 38: 1049-1053
14. Halkin A, Mehran R, Casey CW et al. Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: Results from the TAXUS-IV Trial. Am Heart J 2005; 150: 1163-1170
15. Heuser R, Lopez A, Kuntz R et al. SMART: The microstent's ability to limit restenosis trial. Catheter Cardiovasc Interv 2001; 52: 269-277; discussion 278
16. Baim DS, Cutlip DE, Midei M et al. Final results of a randomized trial comparing the MULTI-LINK stent with the Palmaz-Schatz stent for narrowings in native coronary arteries. Am J Cardiol 2001; 87: 157-162
17. Baim DS, Cutlip DE, O'Shaughnessy CD et al. Final results of a randomized trial comparing the NIR stent to the Palmaz-Schatz stent for narrowings in native coronary arteries. Am J Cardiol 2001; 87: 152-156
18. Cutlip DE, Baim DS, Ho KK et al. Stent thrombosis in the modern era: A pooled analysis of multicenter coronary stent clinical trials. Circulation 2001; 103: 1967-1971
19. Anonymous.K/DOQI clinical practice guidlines for chornic kidney disease: evaluation, classification, and stratification. Kidney disease outcomes quality initiative. Am J Kidney Dis 2002; 39: S1-S246
20. Couchoud C, Pozet N, Labeeuw M, Pouteil-Noble C. Screening early renal failure: Cut-off values for serum creatinine as an indicator of renal impairment. Kidney Int 1999; 55: 1878-1884
21. Lin J, Knight EL, Hogan ML, Singh AK. A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease. J Am Soc Nephrol 2003; 14: 2573-2580
22. Verhave JC, Gansevoort RT, Hillege HL, De Zeeuw D, Curhan GC, De Jong PE. Drawbacks of the use of indirect estimates of renal function to evaluate the effect of risk factors on renal function. J Am Soc Nephrol 2004; 15: 1316-1322
23. Ashby DT, Dangas G, Mehran R et al. Comparison of clinical outcomes using stents versus no stents after percutaneous coronary intervention for proximal left anterior descending versus proximal right and left circumflex coronary arteries. Am J Cardiol 2002; 89: 1162-1166
24. Iakovou I, Mintz GS, Dangas G et al. Optimal final lumen area and predictors of target lesion revascularization after stent implantation in small coronary arteries. Am J Cardiol 2003; 92: 1171-1176
25. Ashby DT, Mehran R, Aymong EA et al. Comparison of outcomes in men versus women having percutaneous coronary interventions in small coronary arteries. Am J Cardiol 2003; 91: 979-981, A974, A977
26. Canto JG, Allison JJ, Kiefe CI et al. Relation of race and sex to the use of reperfusion therapy in Medicare beneficiaries with acute myocardial-infarction. N Engl J Med 2000; 342: 1094-1100
27. Chen J, Rathore SS, Radford MJ, Wang Y, Krumholz HM. Racial differences in the use of cardiac catheterization after acute myocardial infarction. N Engl J Med 2001; 344: 1443-1449
28. Kuntz RE, Hinohara T, Robertson GC, Safian RD, Simpson JB, Baim DS. Influence of vessel selection on the observed restenosis rate after endoluminal stenting or directional atherectomy. Am J Cardiol 1992; 70: 1101-1108
29. Kuntz RE, Gibson CM, Nobuyoshi M, Baim DS. Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. J Am Coll Cardiol 1993; 21: 15-25.
30. Kuntz RE, Safian RD, Carrozza JP, Fishman RF, Mansour M, Baim DS. The importance of acute luminal diameter in determining restenosis after coronary atherectomy or stenting. Circulation 1992; 86: 1827-1835
31. Cohen DJ, Doucet M, Cutlip DE, Ho KK, Popma JJ, Kuntz RE. Impact of smoking on clinical and angiographic restenosis after percutaneous coronary intervention: Another smoker's paradox? Circulation 2001; 104: 773-778
32. Ong AT, van Domburg RT, Aoki J, Sonnenschein K, Lemos PA, Serruys PW. Sirolimus-eluting stents remain superior to bare-metal stents at two years: Medium-term results from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. J Am Coll Cardiol 2006; 47: 1356-1360
33. Rajagopal V, Rockson SG. Coronary restenosis: A review of mechanisms and management. Am J Med 2003; 115: 547-553
34. Lowe HC, Oesterle SN, Khachigian LM. Coronary in-stent restenosis: current status and future strategies. J Am Coll Cardiol 2002; 39: 183-193
35. Chertow GM, Normand SL, McNeil BJ. "Renalism": Inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency. J Am Soc Nephrol 2004; 15: 2462-2468